» Articles » PMID: 38785955

Functional Genomics and Insights into the Pathogenesis and Treatment of Psoriasis

Overview
Journal Biomolecules
Publisher MDPI
Date 2024 May 24
PMID 38785955
Authors
Affiliations
Soon will be listed here.
Abstract

Psoriasis is a lifelong, systemic, immune mediated inflammatory skin condition, affecting 1-3% of the world's population, with an impact on quality of life similar to diseases like cancer or diabetes. Genetics are the single largest risk factor in psoriasis, with Genome-Wide Association (GWAS) studies showing that many psoriasis risk genes lie along the IL-23/Th17 axis. Potential psoriasis risk genes determined through GWAS can be annotated and characterised using functional genomics, allowing the identification of novel drug targets and the repurposing of existing drugs. This review is focused on the IL-23/Th17 axis, providing an insight into key cell types, cytokines, and intracellular signaling pathways involved. This includes examination of currently available biological treatments, time to relapse post drug withdrawal, and rates of primary/secondary drug failure, showing the need for greater understanding of the underlying genetic mechanisms of psoriasis and how they can impact treatment. This could allow for patient stratification towards the treatment most likely to reduce the burden of disease for the longest period possible.

Citing Articles

zDHHC-Mediated S-Palmitoylation in Skin Health and Its Targeting as a Treatment Perspective.

Abdulrahman F, Benford K, Lin G, Maroun A, Sammons C, Shirzad D Int J Mol Sci. 2025; 26(4).

PMID: 40004137 PMC: 11854935. DOI: 10.3390/ijms26041673.

References
1.
Hou Y, Zhu L, Tian H, Sun H, Wang R, Zhang L . IL-23-induced macrophage polarization and its pathological roles in mice with imiquimod-induced psoriasis. Protein Cell. 2018; 9(12):1027-1038. PMC: 6251802. DOI: 10.1007/s13238-018-0505-z. View

2.
Pisarska M, Dunne M, OShea D, Hogan A . Interleukin-17 producing mucosal associated invariant T cells - emerging players in chronic inflammatory diseases?. Eur J Immunol. 2020; 50(8):1098-1108. DOI: 10.1002/eji.202048645. View

3.
Liu M, Degner J, Davis J, Idler K, Nader A, Mostafa N . Identification of HLA-DRB1 association to adalimumab immunogenicity. PLoS One. 2018; 13(4):e0195325. PMC: 5882140. DOI: 10.1371/journal.pone.0195325. View

4.
Hansen A, Cattoglio C, Darzacq X, Tjian R . Recent evidence that TADs and chromatin loops are dynamic structures. Nucleus. 2017; 9(1):20-32. PMC: 5990973. DOI: 10.1080/19491034.2017.1389365. View

5.
Huggins C, Malik R, Lee S, Salotti J, Thomas S, Martin N . C/EBPγ suppresses senescence and inflammatory gene expression by heterodimerizing with C/EBPβ. Mol Cell Biol. 2013; 33(16):3242-58. PMC: 3753923. DOI: 10.1128/MCB.01674-12. View